Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs

Qinyong Gu1, Zeli Zhang1, Christoph G W Gertzen1,2

  • 1Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Journal of Virology
|December 22, 2017
PubMed

Insights

Feline immunodeficiency virus (FIV) Vif protein degrades feline APOBEC3 (A3) antiviral proteins by binding Cullin 5. Researchers identified key FIV Vif residues for CUL5 binding, revealing conserved interactions with HIV-1 Vif but a zinc-independent mechanism in FIV.

Area of Science:

  • Virology and retroviral restriction factors
  • Molecular biology and protein-protein interactions
  • Immunology and host-pathogen interactions

Background:

  • APOBEC3 (A3) enzymes are crucial intrinsic defense mechanisms against retroviral infections, including feline immunodeficiency virus (FIV).
  • FIV's viral infectivity factor (Vif) counteracts A3 proteins by recruiting them for degradation via a Cullin-based E3 ubiquitin ligase complex.
  • The specific domains within FIV Vif responsible for interacting with Cullin proteins, particularly Cullin 5 (CUL5), remain largely uncharacterized.

Purpose of the Study:

  • To elucidate the functional domains of FIV Vif involved in the interaction with Cullin proteins, specifically CUL5.
  • To identify the key residues in FIV Vif and CUL5 that mediate their binding.
  • To compare the FIV Vif-CUL5 interaction mechanism with that of human immunodeficiency virus type 1 (HIV-1) Vif.

Main Methods:

  • Expression of dominant-negative Cullin mutants (CUL2 and CUL5) to assess their impact on feline A3 degradation.
  • Coimmunoprecipitation assays to determine direct binding between FIV Vif and Cullin proteins.
  • Site-directed mutagenesis of conserved amino acid residues in FIV Vif and structural modeling to pinpoint interaction sites.

Main Results:

  • Dominant-negative CUL5, but not CUL2, prevented FIV Vif-mediated degradation of feline A3s, indicating a specific role for CUL5.
  • FIV Vif directly binds to CUL5, and a conserved hydrophobic region (174IR175) within FIV Vif is critical for this interaction.
  • Structural analysis identified the 52LW53 region in CUL5 as important for binding FIV Vif, and this interaction is zinc-independent, unlike HIV-1 Vif.

Conclusions:

  • The study identifies critical residues in FIV Vif and CUL5 that mediate their interaction, essential for the degradation of feline A3 antiviral proteins.
  • The findings reveal conserved structural features in the Vif-CUL5 interaction across different lentiviruses, suggesting evolutionary constraints.
  • A key distinction is the zinc-independent binding of FIV Vif to CUL5, contrasting with the zinc-dependent mechanism observed in HIV-1 Vif.